Advertisement
Review Article| Volume 27, ISSUE 1, P117-131, February 2023

Noninvasive Fibrosis Testing in Chronic Liver Disease Including Caveats

Published:October 17, 2022DOI:https://doi.org/10.1016/j.cld.2022.08.008

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ellis E.L.
        • Mann D.A.
        Clinical evidence for the regression of liver fibrosis.
        J Hepatol. 2012; 56: 1171-1180
        • Tada T.
        • Kumada T.
        • Toyoda H.
        • et al.
        Improvement of liver stiffness in patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response.
        J Gastroenterol Hepatol. 2017; 32: 1982-1988
        • Younossi Z.M.
        • Stepanova M.
        • Younossi Y.
        • et al.
        Epidemiology of chronic liver diseases in the USA in the past three decades.
        Gut. 2020; 69: 564-568
        • Center for Health Statistics N.
        • Table A.-4
        Selected diseases and conditions among adults aged 18 and over, by selected characteristics: United States, 2018.
        (Available at:) (Accessed April 23, 2022)
        • Rockey D.C.
        • Caldwell S.H.
        • Goodman Z.D.
        • et al.
        Liver biopsy.
        Hepatology. 2009; https://doi.org/10.1002/hep.22742
        • Shah A.R.
        • Al-Hanayneh M.
        • Chowdhry M.
        • et al.
        Endoscopic ultrasound guided liver biopsy for parenchymal liver disease.
        World J Hepatol. 2019; 11: 335
        • Boyum J.H.
        • Atwell T.D.
        • Schmit G.D.
        • et al.
        Incidence and risk factors for adverse events related to image-guided liver biopsy.
        Mayo Clin Proc. 2016; 91: 329-335
        • Davison B.A.
        • Harrison S.A.
        • Cotter G.
        • et al.
        Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials.
        J Hepatol. 2020; 73: 1322-1332
        • Bedossa P.
        Intraobserver and Interobserver Variations in liver biopsy interpretation in patients with chronic hepatitis C.
        Hepatology. 1994; 20: 15-20
        • de Ritis F.
        • Coltorti M.
        • Giusti G.
        An enzymic test for the diagnosis of viral hepatitis; the transaminase serum activities.
        Clin Chim Acta. 1957; 2: 70-74
        • Reedy D.W.
        • Loo A.T.
        • Levine R.A.
        AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C.
        Dig Dis Sci. 1998; 43: 2156-2159
        • Parkes J.
        • Guha I.N.
        • Roderick P.
        • et al.
        Performance of serum marker panels for liver fibrosis in chronic hepatitis C.
        J Hepatol. 2006; 44: 462-474
        • Pickhardt P.J.
        • Malecki K.
        • Hunt O.F.
        • et al.
        Hepatosplenic volumetric assessment at MDCT for staging liver fibrosis.
        Eur Radiol. 2017; 27: 3060-3068
        • Afdhal N.H.
        Fibroscan (transient elastography) for the measurement of liver fibrosis.
        Gastroenterol Hepatol. 2012; 8 (Available at:) (Accessed April 14, 2022): 605
        • Friedrich-Rust M.
        • Wunder K.
        • Kriener S.
        • et al.
        Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography.
        Radiology. 2009; 252: 595-604
        • Gao Y.
        • Zheng J.
        • Liang P.
        • et al.
        Liver fibrosis with two-dimensional US shear-wave elastography in participants with chronic hepatitis B: a prospective multicenter study.
        Radiology. 2018; 289: 407-415
        • Giannini E.
        • Risso D.
        • Botta F.
        • et al.
        Validity and clinical utility of the aspartate aminotransferase–alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus–related chronic liver disease.
        Arch Intern Med. 2003; 163: 218-224
        • Lin Z.H.
        • Xin Y.N.
        • Dong Q.J.
        • et al.
        Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis.
        Hepatology. 2011; 53: 726-736
        • Angulo P.
        • Hui J.M.
        • Marchesini G.
        • et al.
        The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.
        Hepatology. 2007; 45: 846-854
        • Loomba R.
        • Adams L.A.
        Recent advances in clinical practice Advances in noninvasive assessment of hepatic fibrosis.
        Gut. 2020; 69: 1343-1352
        • Patel K.
        • Nelson D.R.
        • Rockey D.C.
        • et al.
        Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
        Clin Gastroenterol Hepatol. 2008; 6: 242-247
        • Cassinotto C.
        • Lapuyade B.
        • Mouries A.
        • et al.
        Noninvasive assessment of liver fibrosis with impulse elastography: comparison of supersonic shear imaging with ARFI and FibroScan Ò.
        (Available at:) (Accessed April 17, 2022)
        • Zhang Y.N.
        • Fowler K.J.
        • Ozturk A.
        • et al.
        Liver fibrosis imaging: a clinical review of ultrasound and magnetic resonance elastography.
        J Magn Reson Imaging. 2020; 51: 25
        • Barr R.G.
        • Ferraioli G.
        • Palmeri M.L.
        • et al.
        Elastography assessment of liver fibrosis: society of radiologists in ultrasound consensus conference statement.
        Radiology. 2015; 276: 845-861
        • Castéra L.
        • Foucher J.
        • Bernard P.H.
        • et al.
        Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations.
        Hepatology. 2010; 51: 828-835
        • Afdhal N.H.
        Fibroscan (transient elastography) for the measurement of liver fibrosis.
        Gastroenterol Hepatol. 2012; 8 (Available at:) (Accessed April 18, 2022): 605
        • Yin M.
        • Glaser K.J.
        • Talwalkar J.A.
        • et al.
        Hepatic MR elastography: clinical performance in a series of 1377 consecutive examinations1.
        Radiology. 2016; 278: 114-124
        • Cassinotto C.
        • Lapuyade B.
        • Aiẗ-Ali A.
        • et al.
        Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography--comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease.
        Radiology. 2013; 269: 283-292
        • Ferraioli G.
        • Tinelli C.
        • Lissandrin R.
        • et al.
        Ultrasound point shear wave elastography assessment of liver and spleen stiffness: effect of training on repeatability of measurements.
        Eur Radiol. 2014; 24: 1283-1289
        • Xiao H.
        • Shi M.
        • Xie Y.
        • et al.
        Comparison of diagnostic accuracy of magnetic resonance elastography and Fibroscan for detecting liver fibrosis in chronic hepatitis B patients: a systematic review and meta-analysis.
        PLOS ONE. 2017; 12: e0186660
      1. HERC: measuring costs for cost-effectiveness analysis.
        (Available at:) (Accessed April 18, 2022)
      2. Increasing Use of percutaneous liver biopsy accompanied by growing costs.
        (Available at:) (Accessed April 18, 2022)
        • Tapper E.B.
        • Saini S.D.
        • Sengupta N.
        Extensive testing or focused testing of patients with elevated liver enzymes.
        J Hepatol. 2017; 66: 313-319
        • Carlson J.J.
        • Kowdley K.v.
        • Sullivan S.D.
        • et al.
        An evaluation of the potential cost-effectiveness of noninvasive testing strategies in the diagnosis of significant liver fibrosis.
        J Gastroenterol Hepatol. 2009; 24: 786
        • Vilar-Gomez E.
        • Lou Z.
        • Kong N.
        • et al.
        Cost effectiveness of different strategies for detecting cirrhosis in patients with Nonalcoholic fatty liver disease based on United States health care system.
        Clin Gastroenterol Hepatol. 2020; https://doi.org/10.1016/j.cgh.2020.04.017
        • Congly S.E.
        • Shaheen A.A.
        • Swain M.G.
        Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting.
        PLOS ONE. 2021; 16: e0251741
        • Salkic N.N.
        • Cickusic E.
        • Jovanovic P.
        • et al.
        Online combination algorithm for noninvasive assessment of chronic hepatitis B related liver fibrosis and cirrhosis in resource-limited settings.
        Eur J Intern Med. 2015; https://doi.org/10.1016/j.ejim.2015.07.005
        • Patel K.
        • Sebastiani G.
        Limitations of noninvasive tests for assessment of liver fibrosis.
        JHEP Rep. 2020; 2: 100067
      3. Noninvasive tests for hepatic fibrosis - medical clinical policy bulletins | aetna.
        (Available at:) (Accessed April 18, 2022)
        • Nowotny F.
        • Schmidberger J.
        • Schlingeloff P.
        • et al.
        Comparison of point and two-dimensional shear wave elastography of the spleen in healthy subjects.
        World J Radiol. 2021; 13: 137
        • Kennedy P.
        • Wagner M.
        • Castéra L.
        • et al.
        Quantitative elastography methods in liver disease: Current evidence and Future Directions.
        Radiology. 2018; 286: 738
      4. Return on Investment (ROI) of vibration-controlled transient... : Official journal of the American College of Gastroenterology | ACG.
        (Available at:) (Accessed April 18, 2022)
        • Pinzani M.
        • Vizzutti F.
        • Arena U.
        • et al.
        Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography.
        Nat Clin Pract Gastroenterol Hepatol. 2008; 5: 95-106
        • Poynard T.
        • Morra R.
        • Halfon P.
        • et al.
        Meta-analyses of FibroTest diagnostic value in chronic liver disease.
        BMC Gastroenterol. 2007; 7: 40
        • Huang L.L.
        • Lin H.M.
        • Kang N.L.
        • et al.
        Effect of liver inflammation on accuracy of FibroScan device in assessing liver fibrosis stage in patients with chronic hepatitis B virus infection.
        World J Gastroenterol. 2021; 27: 641
        • Arena U.
        • Vizzutti F.
        • Corti G.
        • et al.
        Acute viral hepatitis increases liver stiffness values measured by transient elastography.
        Hepatology. 2008; 47: 380-384
        • Zeng J.
        • Zheng J.
        • Jin J.Y.
        • et al.
        Shear wave elastography for liver fibrosis in chronic hepatitis B: adapting the cut-offs to alanine aminotransferase levels improves accuracy.
        Eur Radiol. 2019; 29: 857-865
        • Venkatesh S.K.
        • Wells M.L.
        • Miller F.H.
        • et al.
        Magnetic resonance elastography: beyond liver fibrosis—a case-based pictorial review.
        Abdom Radiol (Ny). 2018; 43: 1590
        • Imbert-Bismut F.
        • Ratziu V.
        • Pieroni L.
        • et al.
        Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.
        Lancet. 2001; 357: 1069-1075
        • Rockey D.C.
        • Bissell D.M.
        Noninvasive measures of liver fibrosis.
        Hepatology. 2006; 43: S113-S120
        • Volpi N.
        • Schiller J.
        • Stern R.
        • et al.
        Role, metabolism, chemical modifications and applications of hyaluronan.
        Curr Med Chem. 2009; 16: 1718-1745
        • Cristoferi L.
        • Calvaruso V.
        • Overi D.
        • et al.
        Accuracy of transient elastography in assessing fibrosis at diagnosis in Naïve patients with primary biliary cholangitis: a dual cut-Off approach.
        Hepatology. 2021; 74: 1496-1508
        • Tapper E.B.
        • Challies T.
        • Nasser I.
        • et al.
        The performance of vibration controlled transient elastography in a US cohort of patients with non-alcoholic fatty liver disease.
        Am J Gastroenterol. 2016; 111: 677
        • Evaluation de la
        stéatose à partir du FibroScan® par un index ultrasonore de stéatose-validation sur une cohorte de 618 patients VHC.
        • Castéra L.
        • Vergniol J.
        • Foucher J.
        • et al.
        Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.
        Gastroenterology. 2005; 128: 343-350
        • Adhoute X.
        • Foucher J.
        • Laharie D.
        • et al.
        Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: a prospective study.
        Gastroentérol Clin Biol. 2008; 32: 180-187
        • Mueller S.
        • Millonig G.
        • Sarovska L.
        • et al.
        Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis.
        World J Gastroenterol. 2010; 16: 966
        • Pavlov C.S.
        • Casazza G.
        • Nikolova D.
        • et al.
        Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease.
        Cochrane Database Syst Rev. 2015; 1https://doi.org/10.1002/14651858.CD010542.PUB2
      5. Hartl J, Denzer U, Ehlken H, et al. Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis.

        • Lin Y.
        • Li H.
        • Jin C.
        • et al.
        The diagnostic accuracy of liver fibrosis in non-viral liver diseases using acoustic radiation force impulse elastography: a systematic review and meta-analysis.
        PLoS ONE. 2020; 15https://doi.org/10.1371/JOURNAL.PONE.0227358
        • Peker E.
        • Erden A.
        T1 mapping and magnetic resonance elastography: potential new techniques for quantification of parenchymal changes in hepatic amyloidosis.
        Diagn Interv Radiol. 2017; 23: 478
        • Babu A.S.
        • Wells M.L.
        • Teytelboym O.M.
        • et al.
        Elastography in chronic liver disease: modalities, techniques, limitations, and Future Directions.
        Radiographics. 2016; 36: 1987
        • Kim D.K.
        • Choi J.Y.
        • Park M.S.
        • et al.
        Clinical Feasibility of MR elastography in patients with biliary obstruction.
        AJR Am J Roentgenol. 2018; 210: 1273-1278
        • Mariappan Y.K.
        • Dzyubak B.
        • Glaser K.J.
        • et al.
        Application of modifed spinecho-based sequences for hepatic MR elastography: evaluation, comparison with the conventional gradient-echo sequence, and preliminary clinical experience.
        Radiology. 2017; 282: 390-398
        • McPherson S.
        • Hardy T.
        • Dufour J.F.
        • et al.
        Age as a confounding factor for the accurate noninvasive diagnosis of advanced NAFLD fibrosis.
        Am J Gastroenterol. 2017; 112: 740
        • Byenfeldt M.
        • Elvin A.
        • Fransson P.
        On patient related factors and their impact on ultrasound-based shear wave elastography of the liver.
        Ultrasound Med Biol. 2018; 44: 1606-1615
        • Petta S.
        • Wai-Sun Wong V.
        • Bugianesi E.
        • et al.
        Impact of obesity and alanine aminotransferase levels on the diagnostic accuracy for advanced liver fibrosis of noninvasive tools in patients with Nonalcoholic fatty liver disease.
        Am J Gastroenterol. 2019; 114: 916-928
        • Chen J.
        • Yin M.
        • Talwalkar J.A.
        • et al.
        Diagnostic performance of MR elastography and vibration-controlled transient elastography in the detection of hepatic fibrosis in patients with severe to morbid obesity.
        Radiology. 2017; 283: 418
        • Palmeri M.L.
        • Wang M.H.
        • Dahl J.J.
        • et al.
        Quantifying hepatic shear modulus in vivo using acoustic radiation force.
        Ultrasound Med Biol. 2008; 34: 546-558
        • Obrzut M.
        • Atamaniuk V.
        • Chen J.
        • et al.
        Postprandial hepatic stiffness changes on magnetic resonance elastography in healthy volunteers.
        Scientific Rep. 2021; 11: 1-7
        • Fraser J.R.E.
        • Gibson P.R.
        Mechanisms by which food intake elevates circulating levels of hyaluronan in humans.
        J Intern Med. 2005; 258: 460-466
        • Sanyal A.J.
        • van Natta M.L.
        • Clark J.
        • et al.
        Prospective study of outcomes in adults with Nonalcoholic fatty liver disease.
        N Engl J Med. 2021; 385: 1559-1569
        • Mózes F.E.
        • Lee J.A.
        • Selvaraj E.A.
        • et al.
        Diagnostic accuracy of noninvasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis.
        Gut. 2022; 71: 1006-1019